December 2, 2019 – Persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies as they try to navigate a new world of work, according to Deloitte’s global sector outlook report on life sciences. This will require a dramatic change in strategies for leadership, talent and human resources. What’s more, the global life sciences sector is in the midst of a turbulent transformation, making the need for innovative leaders more important than ever.
Recently, Milford, MA-based life science executive search firm Prestige Scientific appointed Butch Hawking as a director and leader of the manufacturing executive search function. He will be located in the firm’s Wilmington, NC, office, conducting national search for biotechnology and pharmaceutical companies with a specialty in chemistry, manufacturing and controls, and technical operations functions.
“We are very fortunate to have Butch join our executive search team in the Wilmington office,” said Stephen Provost, co-founder and managing partner of Prestige Scientific. “His results in executive search easily put him, without question, in the top one percent of the profession in his peer group. He brings a unique, well rounded background to the team having been in the executive search industry as well as leading large global sales organizations.”
“He has the ability to both understand the client’s needs upfront and see a search through to completion,” said Mr. Provost. “We’re looking forward to Butch making an immediate impact for our clients by building their manufacturing management and executive teams.”
Prior to joining the Prestige Scientific, Mr. Hawking was one of the first five managing directors in the firm history for Kaye/Bassman International in Plano, TX. He is a former college basketball player with the U.S. Air Force Academy and coach of Division I Kansas State University.
Prestige Scientific advises clients on recruiting impactful leaders with proven abilities to increase revenue, decrease expenses and mitigate business risk in the drug development process. The firm provides clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. On average, the firm’s searches are completed in 59 days, with the eventual hire presented to the client by the ninth day of the search, and with a success rate of 99.7 percent.
Closing the Deal with Candidates in the Life Sciences SectorClosing the Deal with Candidates in the Life Sciences Sector
The competitive landscape of the life sciences industry is transforming recruiting. “Growing pressure to rapidly advance scientific discovery and expand market share is making the competition to attract top talent as fierce as ever.”
In June, Prestige Scientific opened its first European office in Amsterdam and appointed Brandan Sweeney as director of the new location. The expansion to Amsterdam is largely in response to the European Medicines Agency’s recent relocation there, said the firm. Mr. Sweeney is charged with leading the expansion of the regulatory affairs practice in Western Europe. His main focus is on regulatory affairs clinical strategy, regulatory affairs CMC, regulatory affairs operations and regulatory affairs post market with research-based life science companies. Prior to joining Prestige Scientific, Mr. Sweeney spent 15 years as vice president of regulatory affairs, recruiting for U.S.-based regulatory affairs national search firm Dennis Partners.
“Brandan’s considerable knowledge of the regulatory challenges our clients face in the life science industry, paired with his global experience in identifying top regulatory talent, will be tremendous assets in our expansion to the Western European markets,” said Mr. Provost. “We look forward to expanding our European presence, with the addition of Brandan, and giving our clients the same high-quality results they’ve come to expect during the last 17 years.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media